Skip to main content
OpenTrials

Clinical trial condition

Connective Tissue Diseases

Explore clinical trials studying Connective Tissue Diseases. Study availability and eligibility vary by location and protocol.

5,745 public trials 878 recruiting studies
Refine in advanced search Browse all conditions

Connective Tissue Diseases trial results

Completed

A Study of PF-06438179 (Infliximab-Pfizer) and Infliximab in Combination With Methotrexate in Subjects With Active Rheumatoid Arthritis (REFLECTIONS B537-02).

NCT02222493

Conditions
Arthritis, Arthritis, Rheumatoid, Autoimmune Diseases, +7 more
Locations
  • Achieve Clinical Research, LLC Birmingham, Alabama, United States
  • Clinical and Translational Research Center of Alabama, PC Tuscaloosa, Alabama, United States
  • Sun Valley Arthritis Center, Ltd. Peoria, Arizona, United States
  • Arizona Arthritis & Rheumatology Associates, P.C. Phoenix, Arizona, United States
View all 184 locations
View Trial Details
Completed

Usability of an AI for M923 in Subjects With Moderate to Severe RA

NCT02722044

Conditions
Arthritis, Arthritis, Rheumatoid, Autoimmune Diseases, +7 more
Locations
  • Henry Ford Health System Detroit, Michigan, United States
  • Medication Management, LLC Greensboro, North Carolina, United States
  • Lynn Health Science Institute Oklahoma City, Oklahoma, United States
  • Altoona Center for Clinical Research, PC Duncansville, Pennsylvania, United States
View Trial Details
Completed

PF-00489791 For The Treatment Of Raynaud's

NCT01090492

Conditions
Cardiovascular Diseases, Connective Tissue Diseases, Embolism and Thrombosis, +12 more
Locations
  • Stanford Hospital and Outpatient Center Redwood City, California, United States
  • University of Connecticut Health Center Farmington, Connecticut, United States
  • Georgetown University Hospital Washington D.C., District of Columbia, United States
  • Arthritis and Rheumatology of Georgia Atlanta, Georgia, United States
View all 55 locations
View Trial Details
Completed

U-Act-After: An Observational Study on Long-Term Efficacy of Tight Control RoActemra/Actemra (Tocilizumab) and/or Methotrexate in Patients With Early Rheumatoid Arthritis Who Have Participated in the U-Act-Early Study (ML22497)

NCT01918267

Conditions
Arthritis, Arthritis, Rheumatoid, Autoimmune Diseases, +7 more
Locations
  • Medisch Centrum Alkmaar Alkmaar, Netherlands
  • Meander Medisch Centrum; Locatie Lichtenberg Amersfoort, Netherlands
  • Gelre Ziekenhuis Apeldoorn, Lokatie Lukas; Afdeling Interne Geneeskunde Apeldoorn, Netherlands
  • Amphia Ziekenhuis Breda, Netherlands
View all 19 locations
View Trial Details
Completed

An Observational Study to Evaluate the Clinical Effectiveness, Quality of Life, Safety and Tolerability of Tocilizumab (TCZ) in Patients With Rheumatoid Arthritis (RA) in Daily Clinical Practice

NCT02552940

Conditions
Arthritis, Arthritis, Rheumatoid, Autoimmune Diseases, +7 more
Locations
  • ASZ Aalst Aalst, Belgium
  • AZ Sint Lucas Brugge Assebroek, Belgium
  • AZ Sint Jan Bruges, Belgium
  • CHU St Pierre (César de Paepe) Brussels, Belgium
View all 22 locations
View Trial Details

Related conditions